MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0157371
Lamium Pharmaceuticals Private Limited
Lamium Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.41 Lakh
▼ 17% YoY
Net profit · FY 2025
₹17,128
Net margin 0.3%
EBITDA · FY 2025
₹39,458
EBITDA margin 0.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Lamium Pharmaceuticals Private Limited
Data last updated:
Lamium Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC173456. Its GSTIN is 27AADCL4556G1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vijaykumar Ramrao Mangrule and Sadashiv Ramrao Mangrule.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 555 Bajare Mala Vadki Haveli, Pune, Maharashtra, India – 412307.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.41 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹17,128 (net margin 0.3%) and EBITDA of ₹39,458 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 14% over five years.
Lamium Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0157371). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999PN2017PTC173456
Registration Number 173456
Incorporation Date 17 November 2017
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0157371
Recognitions & Rankings of Lamium Pharmaceuticals
Contact details
Lamium Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address555 Bajare Mala Vadki Haveli, Pune, Maharashtra, India – 412307
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Lamium Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Lamium Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lamium Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Lamium Pharmaceuticals Private Limited, buy the company report.
Financials of Lamium Pharmaceuticals Private Limited
FY 2024 filings availableLamium Pharmaceuticals Private Limited reported revenue of ₹54.41 Lakh (down 17% YoY) for FY 2025.
Revenue · FY 2025
₹54.41 Lakh ▼ 17%
Net profit · FY 2025
₹17,128 margin 0.3%
EBITDA · FY 2025
₹39,458 margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 11%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 54%
3 years · compounded
▲ 8%
5 years · compounded
▼ 1%
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39,458 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,128 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lamium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lamium Pharmaceuticals Private Limited
Lamium Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijaykumar Ramrao Mangrule | Director | 17 Nov 2017 | 8 Years 11 Months | Current |
| Sadashiv Ramrao Mangrule Also directs: Lamisun Pharma (OPC) Private Limited, SMBT Pharma Private Limited | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
Auditor
Lamium Pharmaceuticals Private Limited is audited by SOLANKE AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOLANKE AND ASSOCIATES | FY 2023 | 159851W |
Shareholding
The shareholding of Lamium Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lamium Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lamium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lamium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lamium Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL4556G1ZF | Maharashtra | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Lamium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lamium Pharmaceuticals Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Sadashiv Ramrao Mangrule was appointed as Director on 26 Aug 2021.
AGM
Lamium Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Lamium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Appointed
Sadashiv Ramrao Mangrule was appointed as Director.
Ceased
Prasad Amarkant Kharosekar ceased to be Director.
Ceased
Sadashiv Ramrao Mangrule ceased to be Director.
Ceased
Shivshankar Damodar Survase ceased to be Director.
Appointed
Vijaykumar Ramrao Mangrule was appointed as Director.
Incorporation
17 Nov 2017
Lamium Pharmaceuticals Private Limited was registered on 17 Nov 2017 with Roc Pune & aged 8 years 11 months as per MCA records.
Frequently asked questions
Lamium Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 November 2017 (9+ years old) and is registered under CIN U74999PN2017PTC173456.
Lamium Pharmaceuticals has 2 current directors:
- Vijaykumar Ramrao Mangrule - Director
- Sadashiv Ramrao Mangrule - Director
The latest financial statements of Lamium Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Lamium Pharmaceuticals is 27AADCL4556G1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Lamium Pharmaceuticals is U74999PN2017PTC173456. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lamium Pharmaceuticals was incorporated on 17 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Sadashiv Ramrao Mangrule was appointed as Director on 26 Aug 2021. Prasad Amarkant Kharosekar ceased to be Director on 19 Sep 2020. Sadashiv Ramrao Mangrule ceased to be Director on 11 Mar 2020. Lamium Pharmaceuticals has 5 board changes on record in total.
Yes, Lamium Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0157371).
The registered office of Lamium Pharmaceuticals is at 555 Bajare Mala Vadki Haveli, Pune, Maharashtra, India – 412307.
Lamium Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages